Oryzon presents the results of the clinical study of GynEC-Dx: detection of endometrial cancer product

In de context of the 31st National Congress of the Spanish Society of Gynecology and Obstetrics (S.E.G.O.) held in Seville, Geadic Biotec AIE (joint venture Oryzon and laboratories Reig Jofre) has presented the results of the clinical validation of the test GynEC-Dx, an innovative method for the detection of endometrial cancer, to the gynecologists participating in the project. In the clinical validation of this test, which results will be announced in September, a wide network of hospitals has been involved, led by the Bellvitge Hospital and the Vall d'Hebron University Hospital.